Sign Up to like & get
recommendations!
0
Published in 2021 at "Blood"
DOI: 10.1182/blood.2020008136
Abstract: Anaplastic large cell lymphomas (ALCLs) frequently carry oncogenic fusions involving the anaplastic lymphoma kinase (ALK) gene. Targeting ALK using tyrosine kinase inhibitors (TKIs) is a therapeutic option in cases relapsed after chemotherapy, but TKI resistance…
read more here.
Keywords:
ptpn1 ptpn2;
resistance alk;
resistance;
alk ... See more keywords